Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than ...

For decades, researchers have worked to create drugs that teach the immune system to kill cancer cells the way traditional ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

The MMR vaccine is very effective at preventing measles infection, but some people may benefit from an MMR vaccine booster.

Shares in Swedish biotech RhoVac were down 94% in mid-morning trading today after the company revealed a phase 2b trial of its prostate cancer vaccine RV001 showed it was no more effective than ...

It’s been 13 years since the FDA approved its first therapeutic vaccine – Dendreon Pharma’s Provenge (sipuleucel-T) for prostate cancer, which was not a commercial success – and since then ...

Voting is now open for STAT Madness, our bracket-style competition in which readers choose the most impressive biomedical ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment ...

Merck's Q4 2024 results surpassed expectations, driven by strong oncology sales and growth in Keytruda. See why I think MRK ...